UCB

Overview

Compare with another stock.

• TickerUCBJF on OTC Markets Group¹
• Industrychemical industry, pharmaceutical industry¹
• HeadquartersBrussels-Capital Region¹
• Websitewww.ucb.com
• Legal formPublic limited company (Belgium)¹
• Listed onEuronext Brussels (UCB), OTC Markets Group (UCBJF)¹

See how the biggest companies compare on our leaderboards

UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders (including epilepsy), inflammatory disorders (including allergy), and oncology.²

The story

Founded by Emmanuel Janssen on Jan 18, 1928.¹

Leadership

Who has led UCB, and when. Pick a name to see everywhere that person has worked.

• FounderEmmanuel Janssen¹

Products and brands

• biopharmaceutical

Listed on Wikidata.¹

Subsidiaries and ownership

Subsidiaries

• UCB Pharma (France)
• UCB Pharma (Germany)
• UCB Pharma (Netherlands)
• UCB Pharma (United Kingdom)
• Union des Fabriques Belges de Textiles Artificiels

From Wikidata.¹

Acquisitions

1. 1932Union des Fabriques Belges de Textiles Artificiels became a subsidiary¹

Employees over time

• 202510,117¹
• 20249,378¹

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

• 20257.7B EUR¹
• 20246.2B EUR¹

Net income

• 20251.6B EUR¹
• 20241.1B EUR¹

Timeline

1. Jan 18, 1928Founded Founded¹

Links

• Websitewww.ucb.com¹
• X (Twitter)x.com/ucb_news¹
• Facebookwww.facebook.com/UCBBiopharma¹
• Instagramwww.instagram.com/ucbglobal¹
• WikipediaUCB (company)
• WikidataQ902046